No cancer anti tnf

Anti-TNF Alpha Treatment May Not Increase Cancer Risk Among Cancer Survivors With Psoriasis Or Other Immune-Mediated Diseases, Study Suggests

Healio (12/26, Young) reports researchers found that anti-TNF alpha treatment of patients with immune-mediated diseases "who previously had cancer" does not increase the "risk for recurrent or new primary cancers." For the study, researchers recruited patients with psoriasis, rheumatoid arthritis, or inflammatory bowel disease "and a primary cancer between 1999 and 2016 from the Danish National Patient registry and the Danish Cancer registry." The study's authors wrote, "Our real-life observational study provides the scale and duration of follow-up needed to address the safety of anti-TNF therapy in people with a history of cancer. These observations might guide clinical decision-making among providers treating immune-mediated diseases with anti-TNF alpha medications." The findings were published in The Lancet Gastroenterology and Hepatology

Sent from my iPhone

Benjamin Hidalgo-Matlock
Skin Care Physicians of Costa Rica

Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574

Please excuse the shortness of this message, as it has been sent from
a mobile device.